"Hospital especializado em saúde cardiovascular, integrante da Rede D'Or São Luiz."

During the past decade, Hospital do Coração do Brasil conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital do Coração do Brasil" #1 sponsor was "Hospital Israelita Albert Einstein" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Cardiovascular Research Center, Brazil" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital do Coração do Brasil" #1 collaborator was "CytoDyn, Inc." with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital do Coração do Brasil" are "COVID-19 Pneumonia" (2 trials), "Atrial Fibrillation" (1 trials), "Coronary Artery Disease" (1 trials), "Covid19" (1 trials) and "Dyslipidemia" (1 trials). Many other conditions were trialed in "Hospital do Coração do Brasil" in a lesser frequency.

Most popular intervention types in "Hospital do Coração do Brasil" are "Drug" (8 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Leronlimab" (2 trials), "Clopidogrel" (1 trials), "Empagliflozin" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital do Coração do Brasil" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hospital do Coração do Brasil". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital do Coração do Brasil, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital do Coração do Brasil, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".